Indefinite Delivery Contract N0018924DZ017

Award Date 4/26/24
Last Date to Order 10/31/29
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Naval Supply Systems Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) N0018925DZ006 was awarded to Microgenics Corporation, a manufacturer of clinical diagnostic products and toxicology testing solutions. The $775,453.50 single-award contract was issued by the Navy Bureau of Medicine and Surgery, a defense agency, with a period of performance through January 2030. The purpose of this IDC is to provide the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems with a steady supply of...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 23 to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation. The $852,120.80 contract is for the supply of toxicology reagents to support substance abuse testing and treatment programs at military medical facilities and VA hospitals. The contract includes a $160,501.00 firm fixed price delivery order for toxicology reagents....
Microgenics Corporation, a subsidiary of Thermo Electron Corporation, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of the Navy Bureau of Medicine and Surgery for the supply of DRI opiate reagent test kits in support of the DOD Drug Demand Reduction Program. The $750,435.30 IDC has a ceiling value and allows for the issuance of firm-fixed price delivery orders over a 5-year period of performance through May 2028. Microgenics has received multiple task orders...
The Department of Defense (DoD) has awarded Microgenics Corporation, a subsidiary of Thermo Electron Corporation, an indefinite delivery contract (IDC) worth up to $5,515,434.90 to provide benzodiazepine immunoassay reagent kits and related laboratory supplies in support of the DoD Drug Demand Reduction Program (DDRP). This single-award IDC has a period of performance through April 30, 2028 and does not utilize any set-aside designations. Under this IDC, Microgenics has received numerous...
The U.S. Department of the Navy's Bureau of Medicine and Surgery has awarded a single-award, indefinite delivery contract (IDC) to Microgenics Corporation's Clinical Diagnostics Division for the procurement of MDMA/MDA reagent kits. The $1,154,822.40 contract has a performance period from March 2024 to March 2029. This IDC will provide the Department of Defense Drug Demand Reduction Program with a variety of immunoassay reagent test kits and related laboratory supplies to support substance abuse...
Microgenics Corporation, a division of Thermo Electron Corporation's Clinical Diagnostics business, has been awarded multiple firm fixed price delivery orders under an Indefinite Delivery Contract (IDC) by the Department of the Navy Bureau of Medicine and Surgery. The delivery orders, valued from $4,013 to $34,913.10, are for the provision of DRI-ECSTASY PLUS MDMA/MDA and other reagent kits to support the Bureau's drug testing and identification programs at Navy and Marine Corps medical...
The Indefinite Delivery Contract (IDC) award N0018925DZ009 was made by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Alere San Diego, Inc. (a subsidiary of Abbott Laboratories) to provide 6-AM reagent kits for use with Beckman Coulter AU5800 series clinical chemistry analyzers. The $750,102.21 single-award IDC has a period of performance through January 2030 and aims to support the Department of Defense's Drug Demand Reduction Program with up to 500,000...
This Indefinite Delivery Contract (IDC) ID W9124D06A0001 was awarded by the U.S. Department of the Army to Instant Technologies, Inc., a subsidiary of Alere Inc., to provide drug test kits. The single-award IDC has a ceiling value of $1,000,000.00 and a period of performance from November 1, 2005 to October 31, 2008. Under this IDC, a Delivery Order (DO) W9124D06A0001|1E01 was issued on September 28, 2006 with a ceiling value of $4,968.00 and a period of performance through September 30, 2006....
This indefinite delivery contract (IDC) awarded by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Heska Corporation provides reagents and disposable products for use on the DriChem 7000 chemistry and HemaTrue CBC machines. The $278,215 single-award IDC has a period of performance from September 2015 to September 2020. Through a series of firm-fixed price delivery orders under the IDC, Heska Corporation supplies a variety of hematology and chemistry analyzer reagents, consumables, and...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The IDC has a ceiling value of $4,999,999 and runs through November 23, 2025, allowing the DLA to efficiently procure a wide range of pharmaceutical products and medical supplies to support military healthcare needs nationwide. The contract involves the delivery of critical care...
  • N0018924DZ017
    Indefinite Delivery Contract
  • 7
    Federal Contract Awards

This federal Indefinite Delivery Contract (IDC) was awarded by the Navy Bureau of Medicine and Surgery, a defense agency, to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation. The $323,566.47 single-award IDC has an ultimate completion date of October 31, 2029 and is for the delivery of DRI Hydrocodone Reagent Kits, 500ML.

Microgenics is a key supplier for the Department of Defense Drug Demand Reduction Program, providing a wide range of immunoassay reagent test kits and related laboratory supplies to support substance abuse testing and treatment programs at military medical facilities and VA hospitals. Under this IDC, the company has received several firm-fixed price delivery orders totaling over $30,000 from the Navy Bureau of Medicine and Surgery and the Air Force Air Education and Training Command for the supply of hydrocodone, opiate, MDMA/MDA, and benzodiazepine reagent kits. These orders do not have any set-aside designations and are likely issued against Microgenics' existing IDVs, which include a $1.15 million single-award IDC for MDMA/MDA reagents and a $750,435 single-award IDC for DRI opiate reagent test kits.

Generated 11/20/24, 9:05 AM